Sandra A Mitchell
Affiliation: National Institutes of Health
- A thematic analysis of theoretical models for translational science in nursing: mapping the fieldSandra A Mitchell
National Institutes of Health, Clinical Center, Bethesda, MD, USA
Nurs Outlook 58:287-300. 2010..A flexible theoretical stance is essential to simultaneously develop new knowledge and accelerate the translation of that knowledge into practice behaviors and programs of care that support optimal patient outcomes...
- A multicenter pilot evaluation of the National Institutes of Health chronic graft-versus-host disease (cGVHD) therapeutic response measures: feasibility, interrater reliability, and minimum detectable changeSandra A Mitchell
Division of Cancer Control and Population Sciences, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892, USA
Biol Blood Marrow Transplant 17:1619-29. 2011..Research is needed to evaluate inter- and intrarater reliability in larger samples, and to evaluate these response criteria as predictors of outcomes in clinical trials...
- Cancer-related fatigue: the evidence base for assessment and managementSandra A Mitchell
National Institutes of Health, Clinical Center, Bethesda, Maryland 20892, USA
Cancer J 12:374-87. 2006..Cancer-related fatigue contributes to negative outcomes relative to psychosocial and symptom distress, functional status, and quality of life, and yet it is often underdiagnosed and management is frequently suboptimal...
- Determinants of functional performance in long-term survivors of allogeneic hematopoietic stem cell transplantation with chronic graft-versus-host disease (cGVHD)S A Mitchell
Nursing Research, Clinical Center, National Institutes of Health, Bethesda, MD 20852, USA
Bone Marrow Transplant 45:762-9. 2010..004). Results suggest two possible mechanisms underlying impaired functional performance in survivors with cGVHD and underscore the importance of testing interventions to enhance functional capacity and reduce symptom bother...
- Putting evidence into practice: evidence-based interventions for fatigue during and following cancer and its treatmentSandra A Mitchell
National Institutes of Health, Bethesda, MD, USA
Clin J Oncol Nurs 11:99-113. 2007..In addition to offering patients and clinicians a tool to facilitate effective management of the distressing symptom, this evidence-based review identifies gaps in knowledge and research opportunities...
- Cancer-related fatigue: state of the scienceSandra A Mitchell
National Institutes of Health, Clinical Center, 10 Center Drive, Bethesda, MD 20852, USA
PM R 2:364-83. 2010....
- Spiritual well-being in long-term survivors with chronic graft-versus-host disease after hematopoietic stem cell transplantationBrian A Harris
Pain and Palliative Care Service, National Institutes of Health Clinical Center, National Cancer Institute, Bethesda, Maryland 20892, USA
J Support Oncol 8:119-25. 2010..Research is needed to identify factors that diminish Sp-WB and to test interventions designed to strengthen this coping resource in patients experiencing the late effects of treatment...
- National Institutes of Health chronic graft-versus-host disease staging in severely affected patients: organ and global scoring correlate with established indicators of disease severity and prognosisKristin Baird
Pediatric Oncology Branch, National Cancer Institute, Center for Cancer Research, National Institutes of Health, Bethesda, MD 20892, USA
Biol Blood Marrow Transplant 19:632-9. 2013..In this population of severely affected patients, NIH lung score is the strongest predictor of poor overall survival, both alone and after adjustment for other important factors...
- Function, adjustment, quality of life and symptoms (FAQS) in allogeneic hematopoietic stem cell transplantation (HSCT) survivors: a study protocolMargaret F Bevans
National Institutes of Health Clinical Center, Bethesda, MD, USA
Health Qual Life Outcomes 9:24. 2011....
- Oral symptom intensity, health-related quality of life, and correlative salivary cytokines in adult survivors of hematopoietic stem cell transplantation with oral chronic graft-versus-host diseaseJane M Fall-Dickson
National Institute of Nursing Research, Bethesda, MD, USA
Biol Blood Marrow Transplant 16:948-56. 2010..The positive associations between IL-6 and oral cGVHD severity and erythema, as well as the positive trend with oral ulceration, warrant further exploration of this cytokine as a potential biomarker of active oral cGVHD...
- Salivary gland involvement in chronic graft-versus-host disease: prevalence, clinical significance, and recommendations for evaluationMatin M Imanguli
Experimental Transplantation and Immunology Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892, USA
Biol Blood Marrow Transplant 16:1362-9. 2010..Formal evaluation of salivary function using standardized criteria is needed, and this could be incorporated as an outcome measure in clinical trials of cGVHD...
- Sclerotic-type chronic GVHD of the skin: clinical risk factors, laboratory markers, and burden of diseaseKathryn J Martires
Dermatology Branch, Center for Cancer Research, National Cancer Institute, Bethesda, MD, USA
Blood 118:4250-7. 2011..Widespread skin involvement is associated with significant functional impairment, distressing symptoms, and diminished survival. This trial is registered at http://www.clinicaltrials.gov as NCT00331968...
- Favorable outcomes in patients surviving 5 or more years after allogeneic hematopoietic stem cell transplantation for hematologic malignanciesRobert Quan Le
Stem Cell Allotransplantation Section, Hematology Branch, National Heart, Lung, and Blood Institute, NIH, Bethesda, Maryland 20892 1202, USA
Biol Blood Marrow Transplant 16:1162-70. 2010..These results show that 5 or more years after T cell-depleted HSCT for hematologic malignancy most individuals survive disease free with an excellent performance status, preserved physical and psychological health, and excellent HRQL...
- The symptom experience in the first 100 days following allogeneic hematopoietic stem cell transplantation (HSCT)Margaret F Bevans
National Institutes of Health, Clinical Center, 10 Center Drive, Room 2BO1, MSC 1151, Bethesda, MD 20892, USA
Support Care Cancer 16:1243-54. 2008..Despite advances in allogeneic hematopoietic stem cell transplantation (HSCT), post-transplant complications are common, and patients' symptom experience has not been well documented...
- Acute renal failure: early detection and prompt intervention can improve outcomesStacie Coburn
Stem Cell Transplant Program, Greenebaum Cancer Center, University of Maryland, Baltimore, MD, USA
Am J Nurs 102:6-12; quiz 49-52. 2002
- Implementing evidence-based practice: effectiveness of a structured multifaceted mentorship programmeGwenyth R Wallen
Nursing Research and Translational Science National Institutes of Health, Clinical Center, Bethesda, Maryland, USA
J Adv Nurs 66:2761-71. 2010..This paper is a report of the effectiveness of a structured multifaceted mentorship programme designed to implement evidence-based practice in a clinical research intensive environment...
- The cancer survivor's prescription for livingPamela J Haylock
University of Texas Medical Branch, Galveston, USA
Am J Nurs 107:58-70; quiz 71. 2007
- Evidence-based guidelines for the management of neutropenia following outpatient hematopoietic stem cell transplantationFran West
Cancer Center Methodist University Hospital, Memphis, TN, USA
Clin J Oncol Nurs 8:601-13. 2004..Patient and family education, psychosocial support, and coordination of care are key nursing responsibilities...
- Modifying cancer-related fatigue by optimizing sleep qualityAnn Malone Berger
University of Nebraska Medical Center, Omaha, NE 68198 5330, USA
J Natl Compr Canc Netw 6:3-13. 2008....
- Cognitive impairment in patients with brain tumors: assessment and intervention in the clinic settingSherry W Fox
School of Nursing, University of Virginia, Charlottesville, USA
Clin J Oncol Nurs 10:169-76. 2006..The use of cognitive screening to guide timely intervention, such as referral to a neuropsychologist and the provision of anticipatory guidance to people with brain tumors and their families, is discussed...